State-of-the-art of non-hormonal methods of contraception: III. Intrauterine devices

European Journal of Contraception and Reproductive Health Care

Volumn 15, Issue 2, 2010, Pages 96-112

  Sivin, Irving ^a   Batár, Istv́n ^b  

^a POPULATION COUNCIL   (United States)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Efficacy; Intrauterine devices; IUD modes of action; IUDs and ectopic pregnancy; IUDs and pelvic infection; IUDs in current development; Prevalence

Indexed keywords

CONTRACEPTIVE AGENT; COPPER INTRAUTERINE DEVICE; NONSTEROID ANTIINFLAMMATORY AGENT;

ABORTION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLEEDING; CONTRACEPTION; DRUG MECHANISM; ECTOPIC PREGNANCY; EMERGENCY CONTRACEPTION; ENDOMETRIUM CANCER; EVIDENCE BASED PRACTICE; FEMALE FERTILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAUTERINE CONTRACEPTIVE DEVICE; MEDICAL RESEARCH; NANOTECHNOLOGY; NULLIPARA; PAIN; PELVIC INFLAMMATORY DISEASE; PRACTICE GUIDELINE; PREGNANCY RATE; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK BENEFIT ANALYSIS; SEXUALLY TRANSMITTED DISEASE;

FEMALE; HISTORY, 20TH CENTURY; HUMANS; INTRAUTERINE DEVICE EXPULSION; INTRAUTERINE DEVICES; INTRAUTERINE DEVICES, COPPER; PELVIC INFECTION; PREGNANCY;

EID: 77949547943     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.3109/13625180903519885     Document Type: Review

References (93)

1. World contraceptive use 2007. United Nations Department of Economic and Social Affairs. Population Division. http://www.un.org/esa/population/ publications/ contraceptive2007/contraceptive2007.htm (Accessed July 2009).
2. Sivin I. Dose- and age-dependent ectopic pregnancy risks with intrauterine contraception. Obstet Gynecol 1991;78:291-298
3. Kulier R, Helmerhorst FM, O'Brien P, et al. Copper containing, framed intra-uterine devices for contraception. Cochrane Database Syst Rev 2007; Issue 4, Art. No.: CD005347. DOI: 10.1002/14651858.CD005347. pub3 (Accessed July 2009).
4. UNDP, UNFPA, WHO, et al. Long-term reversible contraception - Twelve years of experience with the TCu380A and TCu220C. Contraception 1997;56:341-352
5. Thiery M. Pioneers of the intrauterine device. Eur J Contracept Reprod Health Care 1997;2:15-23.
6. Gräfenberg E. Die Intrauterine Methode der Konzeptionverhütung [The intra-uterine method of birth prevention]. In Haire N, ed. Proceedings of the Third World League for Sexual Reform Congress, London 1929. London: Kegan Paul, Trench, Turner and Company 1930:166-175
7. Gräfenberg E. An intrauterine contraceptive method. In SangerMand Stone HM, eds. The practice of contraception: An international symposium and survey - Proceedings of the 7th International Birth Control Conference, Zurich Switzerland, September 1930. Baltimore, Md: Williams & Wilkins 1931:33-47.
8. Ota TA. Study on birth control with an intrauterine instrument. Jpn J Obstet Gynecol 1934;17:210-214
9. Ishihama A. Clinical studies on intrauterine rings, especially the present state of contraception in Japan and the experiences in the use of intrauterine rings. Yokohama Med Bull 1959;10:89-105.
10. Oppenheimer W. Prevention of pregnancy by the Graefenberg ring method, a re-evaluation after 28 year's experience. Am J Obstet Gynecol 1959;78:446-454
11. Tietze C, Lewitt S. Evaluation of intrauterine devices: Ninth progress report of the Cooperative Statistical Program. Stud Fam Plann 1970;1:1-40.
12. Jain AK. Safety and effectiveness of intrauterine devices. Contraception 1975;11:243-259
13. Sivin I, Stern J. Long-acting, more effective copper T IUDs: a summary of U.S. experience, 1970-1975. Stud Fam Plann 1979;10:263-281
14. Ozalp SS. Copper containing, framed intrauterine devices for contraception: RHL commentary (last revised: 15 December 2006). The WHO Reproductive Health Library. Geneva: World Health Organization. http://apps.who.int/rhl/fertility/contraception/soacom/ en/index.html (Accessed July 2009).
15. Wildemeersch D, Vander Pas H, Thiery M, et al. The Copper-Fix (Cu-Fix): A new concept in IUD technology. Adv Contracept 1988;4:197-205.
16. WHO, Department of Reproductive Health and Research. Annual Technical Report 1999. (WHO/ RHR/00.9) Geneva, 2000:190-191
17. O'Brien P, Marfleet CC. Frameless versus classical intrauterine device for contraception. Cochrane Database Syst Rev 2008, Issue 4. Art. No.: CD003282. DOI: 10.1002/14651858.CD003282.pub2. http:// mrw.interscience.wiley.com/ cochrane/clsysrev/articles/ CD003282/frame.html (Accessed July 2009).
18. Hagenfeldt K. Intrauterine contraception with the copper T device. Effect on trace elements in the endometrium, cervical mucus and plasma. Contraception 1972;6:37-54.
19. Ullmann G, Hammerstein J. Inhibition of sperm motility in vitro by copper wire. Contraception 1972;6:71-76
20. Jonsson BG, Landgren BM, Eneroth P. Effects of various IUDs on the composition of the cervical mucus. Contraception 1991;43:447-458
21. Roblero L, Guadarrama A, Lopez T, et al. Effect of copper ion on the motility, viability, acrosome reaction and fertilizing capacity of human spermatozoa in vitro. Reprod Fertil Dev 1996;8:871-874
22. Sagiroglu N. Phagocytosis of spermatozoa in the uterine cavity of women using intrauterine devices. Int J Fertil 1971;16:1-14.
23. Koch UJ. Sperm migration in the human female genital tract with and without uterine devices. Acta Eur Fertil 1980;2:33-60.
24. Settlage DSF, Motoshima M, Tredway DR. Sperm transport from the external cervical os to the Fallopian tubes in women: A time and quantitation study. Fertil Steril 1973;24:655-661
25. Tredway DR, Umezaki CU, Mishell DR, Jr., et al. Effect of intrauterine devices on sperm transport in the human being: preliminary report. Am J Obstet Gynecol 1975; 123:734-735
26. Aref I, Kandil O, El-Tagi A, et al. Effects of nonmedicated and copper IUDs on sperm migration. Contracept Deliv Syst 1983;4:203-206
27. Sivin I. IUDs are contraceptives not abortifacients: A commentary on research and belief. Stud Fam Plann 1989;20:355-359
28. Ortiz ME, Croxatto HB. The mode of action of IUDs. Contraception 1987;36:37-53.
29. Alvarez F, Brache V, Fernandez E, et al. New insights on the mode of action of intrauterine contraceptive devices in women. Fertil Steril 1988;49:768-773
30. Ortiz, ME, Croxatto HB. Copper T intrauterine device and levonorgestrel intrauterine system: biological basis of their mechanism of action. Contraception 2007; 75:S16-S30.
31. Segal SJ, Alvarez-Sanchez F, Adejuwon CA, et al. Absence of chorionic gonadotropin in sera of women who use intrauterine devices. Fertil Steril 1985;44:214-218
32. Wilcox AJ, Weinberg CR, Wehmann RE, et al. Measuring early pregnancy loss: laboratory and field methods. Fertil Steril 1985;44:366-374
33. Sivin I. Utility and drawbacks of continuous use of a Copper T IUD for 20 years. Contraception 2007;75: S70-5.
34. Mansour D. Copper IUD and LNG IUS compared with tubal occlusion. Contraception 2007;75:S144-51.
35. Peterson HB, Xia Z, Wilcox LS, et al. US collaborative review of sterilization working group. Am J Obstet Gynecol 1996;174:1160-1171
36. Trussell J, Leveque JA, Koenig JD, et al. The economic value of contraception: a comparison of 15 methods. Am J Public Health 1995;85:494-503.
37. Harlap S, Kost K, Forrest JD. Preventing pregnancy, protecting health: A new look at birth control choices in the United States. New York: Alan Gutmacher Institute 1991.
38. Hubacher D, Grimes D. Noncontraceptive health benefits of intrauterine devices: A systematic review. Obstet Gynecol Surv 2002;57:120-128
39. Haugan T, Skjeldestad FE, Hakvorsen LE, et al. A randomized trial on the clinical performance of Nova T380 and Gyne T380 Slimline copper IUDs. Contraception 2007;75:171-176
40. Bahamondes L, Faundes A, Sobreira-Lima B, et al. TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of age. Contraception 2005;72:337-341
41. Sivin I,Diaz S, Pavez M, et al. Two year comparative trial of the Gyne T380 Slimline and the Gyne T380 intrauterine copper devices. Contraception 1991;44: 481-487
42. Moreau C, Trussell J, Rodriguez G, et al. Contraceptive failure rates in France: results from a population-based survey. Human Reprod 2007;22:2422-2427
43. Datey S, Gaur LN, Saxena BN. Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills) - an Indian experience. An ICMR Task Force Study. Indian Council of Medical Research. Contraception 1995;51:155-165
44. El-Badrawi HH, Hafez ES. IUD-induced uterine bleeding. Contracept Deliv Syst 1980;1:303-318
45. Amy JJ, Tripathi V. Contraception for women: An evidence based overview. BMJ 2009;339:b2895 (printed version: 563-8).
46. Sivin I, Stern J, Diaz J, et al. Two years of intrauterine contraception with levonorgestrel and with copper: A randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices. Contraception 1987;35:245-255
47. Andersson K, Odlind V, Rybo G. Levonorgestrelreleasing and copper-releasing (Nova T) IUDs during five years of use: A randomized comparative trial. Contraception 1994;49:56-72.
48. Grimes D, Hubacher D, Lopez LM, et al. Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use. Cochrane Database Syst Rev 2006, Issue 4. Art. No.: CD006034. DOI: 10.1002/14651858.CD006034.pub2. http:// www.cochrane.org/reviews/en/ab006034. html (Accessed July 2009).
49. Xiao B. Chinese experience with intrauterine devices. Contraception 2007;75:S31-4.
50. Beerthuizen RJCM, van Wijck JAM, Eskes TKAB, et al. IUD and salpingitis: A prospective study of pathomorphological changes in the oviducts in IUD users. Eur J Obstet Gynecol Reprod Biol 1982;13:31-41.
51. MishellDRJr., Bell JH, Good RG, et al. The intrauterine device: A bacteriologic study of the endometrial cavity. Am J Obstet Gynecol 1966;96:119-126
52. Farley TM, Rosenberg MJ, Rowe PJ, et al. Intrauterine devices and pelvic inflammatory disease: An international perspective. Lancet 1992;339:785-788
53. Lee NC, Rubin GL, Ory HW, et al. Type of intrauterine device and the risk of pelvic inflammatory disease. Obstet Gynecol 1983;62:1-6.
54. Lee NC, Rubin GL, Borucki R. The intrauterine device and pelvic inflammatory disease revisited: New results from the Women's Health Study. Obstet Gynecol 1988; 72:1-6.
55. Meirik O. Intrauterine devices - upper and lower genital tract infection. Contraception 2007;75:S41-7.
56. Daling JR, Weiss NS, Metch BJ, et al. Primary tubal infertility in relation to the use of an intrauterine device. N Engl J Med 1985;312:937-941
57. Cramer DW, Schiff I, Schoenbaum SC, et al. Tubal infertility and the intrauterine device. N Engl J Med 1985;312:941-947
58. Skjeldestad F, Bratt H. Fertility after complicated and non-complicated use of IUDs. A controlled prospective study. Adv Contracept 1988;4:179-184
59. Wilson JC. A prospective New Zealand study of fertility after removal of copper intrauterine contraceptive devices for conception and because of complications: A four-year study. Am J Obstet Gynecol 1989;160:391-396
60. Hubacher D, Lara-Ricalde R, Taylor DJ, et al. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med 2001;345:561-567
61. Lehfeldt H, Tietze C, Gorstein F. Ovarian pregnancy and the intrauterine device. Am J Obstet Gynecol 1970; 108:1005-1009
62. Vessey M, Doll R, Peto R, et al. A long-term follow-up study of women using different methods of contraception - an interim report. J Biosoc Sci 1976;8:373-427.
63. Beral V. An epidemological study of recent trends in ectopic pregnancy. Br J Obstet Gynaecol 1975;82:775-782
64. Meirik O. Ectopic pregnancy during 1961-1978 in Uppsala county, Sweden. Impact of demographic factors on overall incidence. Acta Obstet Gynecol Scand 1981;60:545-548
65. Egger M, Low N, Smith GD, et al. Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: Ecological analysis. BMJ 1998;316:1776-1780
66. Bakken IJ, Skjeldestad FE. Time trends in ectopic pregnancies in a Norwegian county1970-2004 - a population-based study. Hum Reprod 2006;21:3132-3136
67. Ory HW. Women's Health Study. Ectopic pregnancy and intrauterine contraceptive devices: New perspectives. Obstet Gynecol 1981;57:137-144
68. Gray RH. A case-control study of ectopic pregnancy in developed and developing countries. In: Zatuchni G, Goldsmith A and Sciarra JJ, eds. Intrauterine contraception: Advances and future prospects. Philadelphia: Harper and Row 1985:354-364
69. World Health Organization. A multicenter case-control study of ectopic pregnancy. Clin Reprod Fertil 1985;3: 131-143
70. Franks AL, Beral V, Cates W, Jr., et al. Contraception and ectopic pregnancy risk. Am J Obstet Gynecol 1990; 163:1120-1123
71. Batár I. State-of-the-art of intrauterine contraception. Eur J Contracept Reprod Health Care 2006;11:262-269
72. Li J, Suo J, Huang X, et al. Release behavior of copper ion in a novel contraceptive composite. Contraception 2007;76:233-237
73. Xia X, Xie C, Wang Y, et al. The forces imposed by the novel T-shape Cu/LDPE nanocomposite intrauterine device on the simulated uterine cavity. Contraception 2007;76:326-330
74. Yu J, Li J, Li HG, et al. Comparative study on contraceptive efficacy and clinical performance of the copper/low density polyethylene nanocomposite IUD and the Copper T220C IUD. Contraception 2008;78: 319-323
75. Che Y, Fang KJ, Zhou WJ, et al. Uterine cavity shaped device used in China. J Reprod Contracept 2007;18:72-85.
76. Ni FX, Li J, Li JX, et al. Report on clinic tests for 1050 insertions of MCu functional intrauterine contraceptive device. Chin J Fam Plann 2001;9:308-313
77. World Health Organization, Department of Reproductive Health and Research. Selected practice recommendations for contraceptive use, 2nd edn. Geneva: WHO, 2005.
78. Salem R. New attention to the IUD: Expanding women's contraceptive options to meet their needs. Population Reports, Series B, No.7. Baltimore: Johns Hopkins Bloomberg School of Public Health. The INFO Project, February 2006.
79. Beining RM, Dennis LK, Smith EM, Dokras A. Metaanalysis of intrauterine device use and risk of endometrial cancer. Ann Epidemiol 2008;18:492-499
80. Cheng L, Gülmezoglu AM, Piaggio GGP, et al. Interventions for emergency contraception. Cochrane Database Syst Rev 2008, Issue 1. Art. No.: CD001324. DOI: 10.1002/14651858.CD001324.pub3 http://www. cochrane.org/reviews/ en/ab001324.html (Accessed July 2009).
81. Skouby SO. IUD and induced abortion (article in Danish) Ugeskr Laeger 1976;138:339-341
82. Pakarinen P, Toivonen J, Luukkainen T. Randomized comparison of levonorgestrel and copper releasing intrauterine systems immediately after abortion, with 5 years follow-up. Contraception 2003;68:31-34
83. Rosenfield A, Castadot RG. Early postpartum and immediate postabortion intrauterine device insertion. Am J Obstet Gynecol 1974;118:1104-1114
84. Grimes D, Schulz K, Stanwood N. Immediate postabortal insertion of intrauterine devices. Cochrane Database Syst Rev 2004 Oct.18 Issue 4 Art. No. CD001777.
85. Goodman S, Hendlish SK, Reeves MF, et al. Impact of immediate postabortal insertion of intrauterine contraception on repeat abortion. Contraception 2008;78: 143-148
86. Heikinheimo O, Gissler M, Suhonen S. Age, parity, history of abortion and contraceptive choice affect the risk of repeat abortion. Contraception 2008;78: 149-154
87. Sivin I. Fertility decline and contraceptive use in the International Postpartum Family Planning Program. Stud Fam Plann 1971;2:248-256
88. Grimes DA, Schulz KF, Van Vliet H, et al. Immediate post-partum insertion of intrauterine devices. Cochrane Database Syst Rev 2001, Issue 2. Art. No.: CD003036. DOI: 10.1002/14651858.CD003036. http://apps.who. int/rhl/reviews/ CD003036.pdf (Access November 2009).
89. Batár I, Wildemeersch D, Van Kets H, et al. New technology solves the expulsion problem of immediate postplacental IUD insertion. Br J Fam Plann 1995;20: 137-138
90. Kapp N, CurtisKM. Intrauterine device insertion during the postpartum period:Asystematic review. Contraception 2009;80:327-336
91. Hubacher D. Copper intrauterine device use by nulliparous women: Review of side effects. Contraception 2007;75:S8-11.
92. Stringer EM, Kaseba C, Levy J, et al.Arandomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol 2007;197:144.e1-8
93. Heikinheimo O, Lähteenmäki P. Contraception and HIV infection in women. Hum Reprod Update 2009;15:165-176